Dare Bioscience, Inc. — Capital/Financing Update 2024

May 8, 2024

CORRESP 1 filename1.htm

Daré Bioscience, Inc.

3655 Nobel Drive, Suite 260

San Diego, California 92122

May 8, 2024

Via EDGAR

U.S. Securities and Exchange Commission

Division of Corporate Finance

100 F Street, NE

Washington, DC 20549

Attn: Daniel Crawford

Re:
Registration
Statement on Form S-3 (File No. 333-278380)
Acceleration
Request

Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities Act of 1933, as amended, Daré Bioscience, Inc. hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced registration statement to Friday, May 10, 2024, at 4:01 p.m., Eastern Time, or as soon thereafter as practicable.

If you have any questions regarding this request, please contact Scott Stanton of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. at (858) 314-1880.

Sincerely,
Daré
Bioscience, Inc.
/s/
MarDee Haring-Layton
MarDee
Haring-Layton
Chief
Accounting Officer

cc:
Scott
Stanton, Esq.
Jessica
Zhang, Esq

Field: Page; Sequence: 1; Options: Last

Field: /Page